News

September 12, 2019 Contact: Sarah Seagraves, Senior VP for Marketing (405) 813-2403 sseagraves@i2E.org Oklahoma-based Kirrhos Pharmaceuticals is developing a novel, first-in-class treatment for a severe form of non-alcoholic fatty liver disease known as NASH OKLAHOMA CITY — i2E, Inc., recently led an $850,000 seed investment in Oklahoma City-based Kirrhos Pharmaceuticals, which is developing a therapeuticRead more

By Scott Meacham Copyright © 2015 The Oklahoma Publishing Co. Angel investors are those critical investors who invest at the very earliest stage in start-ups. Recently, Marianne Hudson, executive director of the Angel Capital Association (ACA), came to Oklahoma to share the ACA’s perspective on current trends in angel investing. SeedStep Angels, which is managedRead more

In the world of angel investing, the law of unintended consequences just struck and struck hard with proposed new accreditation rules for investors.

An interesting thing happens when successful entrepreneurs become angel investors and participate on due diligence teams; they become more focused on eliminating pitfalls

Even as venture capitalists retreat further from early stage opportunities, the important news for entrepreneurs is that angel investors continue to invest.